Tue, 18 Feb 2020 17:57:05: Five Prime Therapeutics’ pancreatic cancer combo with Opdivo a bust

Tue, 18 Feb 2020 13:50:05: Crossover round, check. New team of biopharma execs, check. Now, Imara wants an IPO

Tue, 18 Feb 2020 13:37:59: PharmaMar, Jazz get FDA priority review for lung cancer drug

Tue, 18 Feb 2020 13:21:14: Gene therapy tackles tau tangles in mouse models of dementia

Tue, 18 Feb 2020 12:59:49: Vifor buys priority review voucher for vadadustat filing

Tue, 18 Feb 2020 12:47:46: After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful

Fri, 14 Feb 2020 13:58:08: Novimmune unit nabs Takeda milestone payment for hemophilia work

Fri, 14 Feb 2020 13:40:09: China's CICC Capital raises $229M biologic investment fund

Fri, 14 Feb 2020 12:26:31: Targeting the 'clock gene' in obesity to slow triple-negative breast cancer

Fri, 14 Feb 2020 10:42:44: Melinta seeks buyout bids to secure escape from bankruptcy

Fri, 14 Feb 2020 08:55:52: AstraZeneca cans cancer pipeline efforts

Thu, 13 Feb 2020 20:35:27: Chutes & Ladders—Ex-Pfizer R&D head Abraham joins Vividion

Thu, 13 Feb 2020 13:17:47: Bristol-Myers' CAR-T gets priority review, mid-August PDUFA date

Thu, 13 Feb 2020 12:46:39: Ipsen takes €669M hit as palovarotene's prospects wither

Thu, 13 Feb 2020 12:46:34: How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes

Thu, 13 Feb 2020 10:29:44: Deciphera nabs speedy review for GIST cancer hopeful

Thu, 13 Feb 2020 09:40:29: CROs, clinical researchers brace for impact of coronavirus shutdown across China

Wed, 12 Feb 2020 14:46:25: Ligand snags Roche-partnered drug in Icagen buyout

Wed, 12 Feb 2020 14:04:39: J&J allies with BARDA to accelerate coronavirus vaccine program

Wed, 12 Feb 2020 12:45:53: ALX raises $105M for midphase trials of CD47 cancer drug

Wed, 12 Feb 2020 12:24:08: Attacking pancreatic cancer with the help of the virus that causes foot-and-mouth disease in cows

Tue, 11 Feb 2020 13:59:00: Trump tries again to reduce NIH budget, spares FDA from cuts

Tue, 11 Feb 2020 13:31:13: Ex-Pfizer oncology R&D lead lands at Fierce 15 winner Vividion Therapeutics

Tue, 11 Feb 2020 12:56:35: LogicBio rocked by FDA clinical hold on genome editing trial

Tue, 11 Feb 2020 09:19:48: Trial flops see Pfizer cut GlycoMimetics pact, Merck ax KalVista research deal